Recovery of NK(CD56+CD3-) Cells after One Year of Tenofovir Therapy for Chronic Hepatitis B Infection.

Natural killer (NK) cells have been reported to be dysfunctional in chronic hepatitis B (CHB) infection. However, the functional recovery of NK cells under antiviral therapeutic agents in CHB was not clearly understood. In this study, we investigated the phenotypic changes of NK(CD56+CD3-) cells in terms of their functional markers (CD16, NKG2A, NKG2D) during tenofovir therapy in CHB. The frequency of NK(CD56+CD3-) cells in CHB patients was significantly increased after 12 months of tenofovir therapy when compared with baseline. The expression levels of CD16+/CD56+CD3- and NKG2A+/CD56+CD3- cells were also affected by tenofovir treatment. In addition, there was a positive correlation between the proportion of NK(CD56+CD3-) cells and HBV DNA (log copies/ml) in CHB patients.

[1]  N. Kootstra,et al.  Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir. , 2015, The Journal of infectious diseases.

[2]  B. Rehermann.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells , 2013, Nature Medicine.

[3]  Hyosun Cho.  Phenotypic characteristics of natural killer cells in acute hepatitis , 2013, Journal of Microbiology.

[4]  Yan-fang Jiang,et al.  Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir , 2013, Clinical and experimental pharmacology & physiology.

[5]  M. Maini,et al.  NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection , 2013, Front. Immunol..

[6]  Yan-fang Jiang,et al.  Treatment with Telbivudine Positively Regulates Antiviral Immune Profiles in Chinese Patients with Chronic Hepatitis B , 2012, Antimicrobial Agents and Chemotherapy.

[7]  M. Mondelli,et al.  Natural killer cell functional dichotomy: a feature of chronic viral hepatitis? , 2012, Front. Immun..

[8]  Milton W. Taylor,et al.  Natural killer inhibitory receptor expression associated with treatment failure and interleukin‐28B genotype in patients with chronic hepatitis C , 2011, Hepatology.

[9]  H. Janssen,et al.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. , 2011, Journal of hepatology.

[10]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[11]  M. Mondelli,et al.  Natural killer cells in viral hepatitis: facts and controversies , 2010, European journal of clinical investigation.

[12]  C. Guillermet,et al.  Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. , 2009, Journal of hepatology.

[13]  S. Staszewski,et al.  Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only? , 2009, Current HIV research.

[14]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[15]  W. Kim,et al.  Natural history of hepatitis B virus infection: an update for clinicians. , 2007, Mayo Clinic proceedings.

[16]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[17]  D. Cooper,et al.  Improvements in Parameters of End-Stage Liver Disease in Patients with HIV/HBV-related Cirrhosis Treated with Tenofovir , 2007, Antiviral therapy.

[18]  Rachel E. Owen,et al.  Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections , 2005, Journal of Virology.

[19]  K. Ley,et al.  Trafficking of natural killer cells. , 2004, Current molecular medicine.

[20]  A. Bertoletti,et al.  Translation of immunological knowledge into better treatments of chronic hepatitis B. , 2003, Journal of hepatology.

[21]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[22]  D. Doherty,et al.  Innate and adaptive lymphoid cells in the human liver , 2000, Immunological reviews.

[23]  F. Chisari,et al.  Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. , 1995, The Journal of clinical investigation.